{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:57:22Z","timestamp":1790773042376,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijantimicag.2020.105902","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T02:01:21Z","timestamp":1579226481000},"page":"105902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli"],"prefix":"10.1016","volume":"55","author":[{"given":"Sumanth","family":"Gandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JooHee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"McElvania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2781-359X","authenticated-orcid":false,"given":"Stefan J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Harazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0455-8370","authenticated-orcid":false,"given":"Gautam","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal S.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.105902_bib0001","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1345\/aph.1G232","article-title":"Faropenem medoxomil","volume":"42","author":"Gettig","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0002","unstructured":"Central Drugs Standard Control Organization. List of approved drug from 01.01.2010 to 31.12.2010."},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0003","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/cid\/ciw055","article-title":"Faropenem consumption is increasing in India","volume":"62","author":"Gandra","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0004","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/ciw143","article-title":"The need for global regulation of antibiotics: the case of a generic oral penem","volume":"62","author":"Tiberi","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0006","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41467-018-04059-1","article-title":"Evolution of high-level resistance during low-level antibiotic exposure","volume":"9","author":"Wistrand-Yuen","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0007","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/jac\/dkt044","article-title":"Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model","volume":"68","author":"T\u00e4ngd\u00e9n","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0008","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jac\/dks368","article-title":"Influence of acquired \u03b2-lactamases on the evolution of spontaneous carbapenem resistance in Escherichia coli","volume":"68","author":"Adler","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0009","series-title":"Scoping report on antimicrobial resistance in India","author":"Gandra","year":"2017"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0010","unstructured":"CDC & FDA Antibiotic Resistance Isolate Bank. Enterobacteriaceae Carbapenem Breakpoint Panel."},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0011","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/ijmm.IJMM_18_326","article-title":"Newer \u03b2-lactam\/\u03b2-lactamase inhibitor for multidrug-resistant gram-negative infections: Challenges, implications and surveillance strategy for India","volume":"36","author":"Veeraraghavan","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0012","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jgar.2016.05.007","article-title":"Faecal carriage rate of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in hospitalised patients and healthy asymptomatic individuals coming for health check-up","volume":"6","author":"Babu","year":"2016","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0013","series-title":"Methods for dilution antimicrobial susceptibility testing for bacteria that grew aerobically","year":"2018"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0014","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/jac\/dkg263","article-title":"In vitro activity of faropenem compared with eight agents against fourteen Gram-positive and Gram-negative bacteria by time\u2013kill","volume":"51","author":"Credito","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0015","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1128\/AAC.39.7.1472","article-title":"Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing","volume":"39","author":"Fuchs","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0016","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jac\/dkp435","article-title":"Resistance development profiling of piperacillin in combination with the novel \u03b2-lactamase inhibitor BLI-489","volume":"65","author":"Ruzin","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0017","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/AAC.49.5.1865-1871.2005","article-title":"A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline","volume":"49","author":"McAleese","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0018","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/JCM.00720-13","article-title":"Use of faropenem as an indicator of carbapenemase activity in the Enterobacteriaceae","volume":"51","author":"Day","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0019","doi-asserted-by":"crossref","first-page":"28063","DOI":"10.1038\/srep28063","article-title":"Comparison of six commercial kits to extract bacterial chromosome and plasmid DNA for MiSeq sequencing","volume":"6","author":"Becker","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0020","series-title":"FastQC: a quality control tool for high throughput sequence data. Babraham Bioinformatics","author":"Andrews","year":"2010"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0021","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0022","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J Comput Biol"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0023","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","article-title":"Prokka: rapid prokaryotic genome annotation","volume":"30","author":"Seemann","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0024","series-title":"Engineering and analyzing multicellular systems","first-page":"165","article-title":"Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq","author":"Deatherage","year":"2014"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3201\/eid1302.060747","article-title":"Ertapenem resistance of Escherichia coli","volume":"13","author":"Lartigue","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0026","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1074\/jbc.M115.690156","article-title":"Molecular basis of filtering carbapenems by porins from \u03b2-lactam-resistant clinical strains of Escherichia coli","volume":"291","author":"Bajaj","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0027","doi-asserted-by":"crossref","first-page":"e25825","DOI":"10.1371\/journal.pone.0025825","article-title":"Altered antibiotic transport in OmpC mutants isolated from a series of clinical strains of multi-drug resistant E. coli","volume":"6","author":"Lou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0028","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/mdr.2017.0079","article-title":"Characterization of carbapenem-resistant escherichia coli isolates through the whole-genome sequencing analysis","volume":"24","author":"Luo","year":"2018","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0029","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jac\/dkv475","article-title":"Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli","volume":"71","author":"Adler","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0030","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1128\/jb.179.13.4382-4390.1997","article-title":"Mutational analysis of the linker region of EnvZ, an osmosensor in Escherichia coli","volume":"179","author":"Park","year":"1997","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2020.105902_bib0031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/mdr.2014.0031","article-title":"Fecal carriage rates of extended-spectrum \u03b2-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers","volume":"21","author":"Mathai","year":"2015","journal-title":"Microb Drug Resist"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:33:22Z","timestamp":1760376802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920300418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0924857920300418"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105902","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105902"}}